Why the study?
What are the comparative cardiovascular and hypotensive effects of propranolol, MJ 1999, and quinidine in hypertensive animal models?
What are the comparative cardiovascular and hypotensive effects of propranolol, MJ 1999, and quinidine in hypertensive animal models?
Answers are grounded in this paper and cite their sources.
The hypotensive effect of propranolol at high doses in hypertensive rats appears related to properties shared with quinidine rather than beta-receptor blockade alone.
A comparison of some cardiovascular effects of propranolol, MJ 1999 and quinidine has been made in rats and dogs.2. After intravenous, subcutaneous or oral administration to rats and dogs, propranolol was found to be 2-4 times more potent than MJ 1999 in blocking the chronotropic and vasodepressor responses to intravenously administered isoprenaline.3. Propranolol and quinidine affected the e.c.g. of rats and dogs in a similar manner.4. At dose-levels causing effective blockade of beta-receptors propranolol and MJ 1999 had no hypotensive effect after short- or long-term administration to conscious hypertensive rats and dogs.5. At very high dose-levels propranolol and quinidine, but not MJ 1999, lowered blood pressure in the hypertensive rat. This effect of propranolol is probably related to one or more of the properties that propranolol and quinidine have in common rather than to a blockade of beta-receptors.6. The possible relevance of these results to the use of propranolol as a hypotensive agent in man is discussed.
No takes yet. Share an insight, caveat, or question.
Farmer et al. (1968) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: